How Dabur is upping its ayurvedic game
The 137-year-old company is capitalising on its herbal heritage and banking on nine power brands to grow during the pandemic23-05-2021
23-05-2021
Dabur India to focus on bolstering production capacity, cost optimisation measures
Sees tailwind for healthcare portfolio13-05-2021
DABUR INDIA LTD. - 500096 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Submission of Transcript of Investors' Conference Call for Dabur India Limited - Q4 FY 2020-21 Financial Results13-05-2021
Khoday Group, Dabur Research Foundation launches ViraNorm' to fight Covid-19
The drug is add-on therapy for asymptomatic and symptomatic Covid patients.12-05-2021
Dabur India enters pain relief spray category
The product has already been launched across e-commerce platforms and through regular retail channels10-05-2021
Dabur India Ltd - 500096 - Announcement under Regulation 30 (LODR)-Investor Presentation
Submission of Revised Investors Communication dated May 07, 202110-05-2021
Dabur India Ltd - 500096 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication of Audited Financial Results for he quarter and year ended on 31st March, 202108-05-2021
Dabur India's consolidated net profit rises 34.4% in Q4 on low base
The maker of honey, chyawanprash, oils and juices had reported a net profit of Rs 281.6 crore last year07-05-2021
DABUR INDIA LTD. - 500096 - Announcement under Regulation 30 (LODR)-Dividend Updates
Board of Directors of the Company in its meeting held today on May 7, 2021 has recommended Final Dividend of Rs.3.00 per equily share having face value of Re. l/- each (i.e, 300 %) for the financial year 2020-21.07-05-2021
DABUR INDIA LTD. - 500096 - Announcement under Regulation 30 (LODR)-Investor Presentation
Submission of Investor Presentation being issued by the Company.07-05-2021